BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 1, 2026
Home » Authors » Amanda Pedersen

Amanda Pedersen

Articles

ARTICLES

Lab tech invents system to prevent needle sticks

July 10, 2012
By Amanda Pedersen

Sanovas' microsurgical lung technology snags spotlight

July 9, 2012
By Amanda Pedersen

IBD: an equal-opportunity disease!

July 6, 2012
By Amanda Pedersen
Crohn’s and Ulcerative Colitis, known collectively as inflammatory bowel disease (IBD), do not discriminate between age, race, gender, economic status, or geographic borders. It is truly an equal-opportunity disease! I was 18, a freshman in college, when I was diagnosed with ulcerative colitis (UC) and was told I was “too young” to be that sick. IBD was an old-person's disease, my gastroenterologist said. He was wrong, of course. Because my symptoms were not taken seriously from the beginning, I continued to get worse over the course of the next three years of college. Looking back, I don’t know how I managed...
Read More

Researchers inject gas-filled microparticles into bloodstream

July 6, 2012
By Amanda Pedersen

Trovagene to collaborate with MD Anderson Cancer Center

July 5, 2012
By Amanda Pedersen

HEAT study to compare bare platinum to hydrogel coils

July 3, 2012
By Amanda Pedersen
MicroVention (Tustin, California), a subsidiary of Terumo (Tokyo), said it has begun enrolling patients in its Hydrogel Endovascular Aneurysm Treatment (HEAT) trial, designed to compare the use of coiling technologies to treat intracranial aneurysms. The prospective, randomized, international multi-center study will pit the company's MicroVention hydrogel coils against bare platinum coils. The HEAT trial will enroll up to 600 patients from about 30 sites around the world.
Read More

Dust settles, industry reacts to aftershock of SCOTUS vote

July 2, 2012
By Amanda Pedersen
Now that the dust is beginning to settle in the aftershock of the Supreme Court decision to uphold the Affordable Care Act, experts from all sides of the issue were eager to share their views Friday on the implication of the healthcare law going forward.
Read More

Living with a pain in the rear

June 29, 2012
By Amanda Pedersen
I am living with a pain in the rear. Casey Abrams, a musician and American Idol alumnus, would say I am living with a “chip on my shoulder,” but I prefer to be as literal as possible. So yes, I live with a pain in the rear – along with about 1.4 million other Americans who have been diagnosed with ulcerative colitis (UC) and Crohn’s disease – collectively known as inflammatory bowel disease (IBD). In advance of releasing his debut album today (June 26), Abrams created an original song, “Chip on Your Shoulder” and music video inspired by his personal...
Read More

Cornell team develops GEDI to fight prostate cancer

June 29, 2012
By Amanda Pedersen

ITRI Forum: Innovation collaboration forged across the Pacific

June 27, 2012
By Amanda Pedersen
View All Articles by Amanda Pedersen

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 31, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 31, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing